Lamy Patrick

CIK 00019612731 companySOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001961273

Recent Transactions

44 trades

Disposition to Issuer
Akero Therapeutics, Inc.
Common Stock
2025-12-09−3,059→ 0 total
Disposition to Issuer
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-12-09−3,421→ 0 total
Disposition to Issuer
Akero Therapeutics, Inc.
Common Stock
2025-12-09−26,832→ 0 total
Disposition to Issuer
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-12-09−84,904→ 0 total
Disposition to Issuer
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-12-09−64,182→ 0 total
Disposition to Issuer
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-12-09−48,679→ 0 total
Disposition to Issuer
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-12-09−11,096→ 0 total
Disposition to Issuer
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-12-09−382→ 0 total
Sale
Akero Therapeutics, Inc.
Common Stock
2025-07-01$52.88/sh−2,000→ 29,891 total
Award
Akero Therapeutics, Inc.
Common Stock
2025-06-30$23.87/sh+193→ 31,891 total
Sale
Akero Therapeutics, Inc.
Common Stock
2025-06-20$54.59/sh−875→ 31,698 total
Sale
Akero Therapeutics, Inc.
Common Stock
2025-06-16$55.09/sh−500→ 32,573 total
Sale
Akero Therapeutics, Inc.
Common Stock
2025-06-16$53.82/sh−1,500→ 33,073 total
Exercise/Conversion
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-06-16−2,000→ 64,182 total
Exercise/Conversion
Akero Therapeutics, Inc.
Common Stock
2025-06-16$19.87/sh+2,000→ 34,573 total
Sale
Akero Therapeutics, Inc.
Common Stock
2025-06-10$54.00/sh−919→ 32,573 total
Exercise/Conversion
Akero Therapeutics, Inc.
Common Stock
2025-06-02$19.87/sh+4,000→ 37,492 total
Exercise/Conversion
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-06-02−4,000→ 66,182 total
Sale
Akero Therapeutics, Inc.
Common Stock
2025-06-02$49.40/sh−600→ 36,892 total
Sale
Akero Therapeutics, Inc.
Common Stock
2025-06-02$51.04/sh−100→ 33,492 total
Sale
Akero Therapeutics, Inc.
Common Stock
2025-06-02$50.46/sh−3,300→ 33,592 total
Exercise/Conversion
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-05-22−4,000→ 84,904 total
Exercise/Conversion
Akero Therapeutics, Inc.
Common Stock
2025-05-22$44.37/sh+4,000→ 37,492 total
Sale
Akero Therapeutics, Inc.
Common Stock
2025-05-22$50.00/sh−4,000→ 33,492 total
Exercise/Conversion
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-05-07−8,000→ 70,182 total
Exercise/Conversion
Akero Therapeutics, Inc.
Common Stock
2025-05-07$19.87/sh+8,000→ 41,492 total
Sale
Akero Therapeutics, Inc.
Common Stock
2025-05-07$42.76/sh−3,299→ 33,492 total
Sale
Akero Therapeutics, Inc.
Common Stock
2025-05-07$42.31/sh−4,701→ 36,791 total
Exercise/Conversion
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-03-03−1,000→ 78,182 total
Exercise/Conversion
Akero Therapeutics, Inc.
Common Stock
2025-03-03$19.87/sh+1,000→ 34,492 total
Sale
Akero Therapeutics, Inc.
Common Stock
2025-03-03$48.09/sh−1,000→ 33,492 total
Exercise/Conversion
Akero Therapeutics, Inc.
Common Stock
2025-01-27$19.87/sh+4,000→ 38,492 total
Sale
Akero Therapeutics, Inc.
Common Stock
2025-01-27$57.03/sh−5,000→ 33,492 total
Exercise/Conversion
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-01-27−4,000→ 79,182 total
Award
Akero Therapeutics, Inc.
Common Stock
2024-12-31$19.69/sh+234→ 34,492 total
Award
Akero Therapeutics, Inc.
Common Stock
2024-12-16+17,400→ 35,258 total
Sale
Akero Therapeutics, Inc.
Common Stock
2024-12-16$29.13/sh−1,000→ 34,258 total
Award
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2024-12-16+52,100→ 52,100 total
Sale
Akero Therapeutics, Inc.
Common Stock
2024-12-10$30.79/sh−925→ 17,858 total
Award
Akero Therapeutics, Inc.
Common Stock
2024-06-28$19.94/sh+221→ 18,783 total
Sale
Akero Therapeutics, Inc.
Common Stock
2024-06-11$22.64/sh−569→ 18,562 total
Award
Akero Therapeutics, Inc.
Common Stock
2023-12-08+18,570→ 18,570 total
Award
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2023-12-08+83,564→ 83,564 total
Award
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2023-01-10−100,000→ 100,000 total

Companies

Akero Therapeutics, Inc.
Senior VP, Commercial Strategy

Recent Filings

Address

C/O AKERO THERAPEUTICS, INC. 601 GATEWAY BLVD, SUITE 350

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov